Smith, Kline & French

E495721

Smith, Kline & French was a major 20th-century pharmaceutical company known for developing and marketing important prescription drugs before becoming part of GlaxoSmithKline.

Try in SPARQL Jump to: Surface forms Statements Referenced by

All labels observed (2)

Label Occurrences
SmithKline 2
Smith, Kline & French canonical 1

Statements (32)

Predicate Object
instanceOf defunct company
pharmaceutical company
activity clinical development
drug discovery
pharmaceutical marketing
businessModel research-based pharmaceutical company
country United States of America
surface form: United States
eventualParentCompany GlaxoSmithKline NERFINISHED
field drug development
medical research
pharmacology
hasSuccessorOrganization GlaxoSmithKline NERFINISHED
SmithKline Beckman NERFINISHED
SmithKline Beecham NERFINISHED
industry pharmaceutical industry
knownFor development of important prescription drugs
marketing of important prescription drugs
research in gastrointestinal drugs
research in psychopharmacology
market global prescription drug market
mergedInto SmithKline Beckman NERFINISHED
SmithKline Beecham NERFINISHED
notableProduct Tagamet NERFINISHED
Thorazine NERFINISHED
partOf SmithKline Beecham NERFINISHED
productType pharmaceutical preparations
prescription drugs
sector healthcare
status defunct
successor GlaxoSmithKline NERFINISHED
timePeriod 20th century
typeOfCompany public company

Referenced by (3)

Full triples — surface form annotated when it differs from this entity's canonical label.

Sir James Black employer Smith, Kline & French
SmithKline Beckman formedByMergerOf Smith, Kline & French
this entity surface form: SmithKline
SmithKline Beckman predecessor Smith, Kline & French
this entity surface form: SmithKline